Intragastric balloons: a temporary treatment for obesity
Allison C
Record ID 32006000058
English, French
Authors' objectives:
The aim of this report is to summarize the available information on the use of intragastric balloons (Trade Mark: Heliosphere Intragastric Balloon System, manufactured by Helioscope in Vienne, France, and distributed by Montreal-based Triumph Medical Products) as a temporary non-surgical treatment for obesity that induces short-term weight loss by partially filling the stomach to achieve satiety and reduce food intake.
Authors' recommendations:
Moderate weight loss may be achieved if patients adhere to a weight-reduction program. Weight gain often recurs when the balloon is removed after six months.
Abdominal pain, nausea, and vomiting are common, particularly in the first week after balloon implantation.
More data on benefits, harm, and cost-effectiveness are required before the intragastric balloon can be compared with other short-term weight loss interventions, including low-caloric diets.
Authors' methods:
Overview
Details
Project Status:
Completed
URL for project:
https://www.ccohta.ca/
Year Published:
2005
URL for published report:
n/a
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Gastric Balloon
- Obesity
- Obesity, Morbid
- Weight Loss
Contact
Organisation Name:
Canadian Coordinating Office for Health Technology Assessment
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553, Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Coordinating Office for Health Technology Assessment (CCOHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.